alphaveSAIPARENT₹521.00

Sai Parenterals Limited

Annual Quarterly₹ CrorePeersINDOCO PANACEABIO HIKAL WINDLAS HESTERBIO DCAL SYNCOMF SOLARAMcap ₹2,302 Cr

View

In ₹ Crore except Per Share 12 Months Ending	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026
Revenue from Operations	96.2	197.9	178.7
Other Income	3.1	2.9	3.7
Total Income	99.3	200.8	182.4
Expenses
+ Cost of Materials Consumed	58.7	114.1	116.1
+ Changes in Inventories	2.6	10.2	-9.9
+ Employee Benefit Expense	10.2	12.2	11.5
+ Finance Costs	5.4	8.4	9.4
+ Depreciation & Amortisation	5.8	8.2	8.1
+ Other Expenses	28.2	35.3	37.4
Total Expenses	110.9	188.4	172.6
EBITDA	-3.6	26.1	23.5
EBIT	-9.3	17.9	15.4
Profit
PBT before Exceptional Items	-11.6	12.4	9.8
Pretax Income	-11.6	12.4	9.8
+ Current Tax	0.6	1.2	4.2
+ Deferred Tax	-5.6	-1.9	-2.3
Tax Expense	-5.0	-0.8	1.9
Net Income	-6.7	13.2	7.9
+ Net Income — Continuing Ops	-6.7	13.2	7.9
+ Other Comprehensive Income	0.0	0.0	0.0
Total Comprehensive Income	-6.7	13.2	7.9
Per Share
Basic EPS	-2.22	4.02	1.79
Diluted EPS	-2.22	4.02	1.79
Other Comprehensive Income — detail
+ Other Comprehensive Income	0.0	0.0	—
+ Items NOT to be Reclassified to P&L	0.0	0.0	—
Per Share — as-filed variants
Basic EPS — Continuing Operations	-2.22	4.02	1.79
Diluted EPS — Continuing Operations	-2.22	4.02	1.79
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	34.8	73.6	72.4
Gross Margin %	36.23	37.20	40.55
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	-11.6	12.4	9.8
Net Income Adj (tax-effected)	-6.7	13.2	7.9
EPS Adj	-2.22	4.02	1.79
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	5.00	5.00	5.00
Paid Up Equity Capital	18.5	22.1	22.1

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.